Fundamental dimension Equity attribute | AMWLPeer $13.57▼-4.37% Cap $230.8MP/E -2.8x QuantScore38/100 | ADVMLeader $4.360.00% Cap $96.26MP/E -1.0x QuantScore44/100 | ALXOPeer $1.17▼-1.68% Cap $161.8MP/E -1.0x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
82/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 25/100 | 40/100 |
Growth Revenue / earnings growth & margins | 33/100 | 1/100 | 29/100 |
Sentiment Analyst ratings, targets & revisions | 22/100 | 77/100 | 96/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.8x | -1.0x | -1.0x |
Forward P/E (next FY) | -5.3x | -0.5x | -2.1x |
EV / EBITDA (TTM) | -0.9x | -1.7x | -1.9x |
Price / Sales | 1.1x | — | — |
Price / Free Cash Flow | -9.8x | -1.4x | -2.3x |
PEG ratio | -0.05 | 0.02 | -0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | -6.89 (Distress) | -32.54 (Distress) | -3.27 (Distress) |
Total debt / equity | 0.01 | -1.60 | 0.07 |
Quick ratio | 2.9x | 0.6x | 9.7x |
Interest coverage | -124.8x | — | -58.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -2.0% | -72.2% | — |
Net income growth YoY | +54.0% | -7.2% | +24.6% |
Gross margin (TTM) | 48.4% | 0.0% | 0.0% |
Operating margin (FY) | -42.2% | -13915.9% | — |
FCF margin (FY) | -26.5% | -9285.0% | — |
5. Trailing price performancePrice change over period |
1M return | +0.7% | 0.0% | -14.0% |
3M return | +25.5% | -10.7% | -42.4% |
6M return | +130.8% | +81.7% | -29.9% |
Year to date | +176.4% | 0.0% | +3.5% |
1Y return | +143.6% | -3.5% | -33.1% |
3Y return | -36.6% | -34.9% | -83.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-70.78 -621.6% premium | $-1.59 -136.5% premium | $0.1287 -89.0% premium |
Wall Street consensus target | $13.00 -4.2% · range $11.00–$16.00 | $8.90 +104.1% · range $2.00–$28.00 | $17.90 +1429.9% · range $1.50–$38.00 |
Consensus stance | 33% Buy67% Hold0% Sell | 63% Buy38% Hold0% Sell | 86% Buy14% Hold0% Sell |